Filing Flows › Volitionrx (VNRX) › Q1 2026
Volitionrx (VNRX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 14, 2026
Volitionrx (VNRX) reported revenue of $985K for the first quarter 2026 (Q1 2026), +300% from a year earlier and +120% from the quarter before. Operating margin was -543.0%, net loss $6.7M (680.5% of revenue).
Volitionrx, Q1 2026: revenue $985K (+300% year over year), operating margin -543.0%, net loss $6.7M, operating cash flow −$5.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $985K | +120% | +300% |
| Operating profit | −$5.3M | — | — |
| Net earnings | −$6.7M | — | — |
| Operating cash flow | −$5.3M | — | — |
What changed
Revenue was $1.0M in Q1 2026, up 300% year over year and up 120% from the previous quarter.
Operating costs exceeded revenue by $5.3M, an operating margin of -543.0%. Total costs grew 10% against revenue growth of 300%. The fastest-growing cost line was General & admin (+17%). The quarter ended with a net loss of $6.7M, wider than the previous quarter's $6.3M loss. Minority interests bore $39K of it: to shareholders the quarter was a loss of $6.7M.
Operating cash flow was −$5.3M. Non-cash charges added back $207K of depreciation and amortization and $225K of share-based compensation. Working capital and other items added $1.0M. Capital expenditures of $9K exceeded it, leaving free cash flow of −$5.3M.
Questions
What was Volitionrx's revenue in the first quarter 2026?
Volitionrx (VNRX) reported revenue of $985K for the first quarter 2026 (Q1 2026), +300% from a year earlier and +120% from the quarter before.
Was Volitionrx profitable in the first quarter 2026?
Operating loss was $5.3M (-543.0% of revenue) and net loss $6.7M.
Source: Volitionrx 10-Q on SEC EDGAR.